BACKGROUND The widespread use of chest CT has significantly enhanced the detection rate of pulmonary nodules (PN). Presently, standard treatments involve regular follow-ups and surgical interventions. Traditional Chinese medicine (TCM) represents a unique treatment method, and an increasing number of studies have shown that TCM treatment may be effective for pulmonary nodules. However, existing research lacks substantial supporting data. This study will be the first systematic review and meta-analysis that aims to evaluate the efficacy and safety of TCM treatment for pulmonary nodules.
METHODS We intend to meticulously search for randomized controlled trials (RCTs) related to Traditional Chinese Medicine (TCM) treatment for pulmonary nodules across seven comprehensive databases:PubMed,Web of Science,The Cochrane Library,Chinese National Knowledge Infrastructure (CNKI),Wanfang Database (Wangfang), Chinese Biomedical Literature Database (CBM), and Technology Periodical Database (VIP). Our primary focus will be on defining the size and characteristics of pulmonary nodules, malignancy risk score, and the overall effectiveness rate as the primary outcomes. Additionally, we will consider adverse events resulting from TCM treatment as secondary outcomes. To assess the risk of bias, we employed RevMan 5.4 software, and for conducting the meta-analysis, we utilized Stata V.15.0 software.
RESULTS From this study, we will determine the efficacy and safety of TCM in the treatment of pulmonary nodule.
CONCLUSION This study will provide preliminary evidence for the efficacy and safety of TCM in the treatment of pulmonary nodule.
Ethics and dissemination Ethical approval is not required because we will be extracting data from published articles and the findings will be published in peer-reviewed journals.
Trial registration PROSPERO registration number CRD42023465975.Registered on September 29, 2023